The use of systemic therapies to prevent progression of inflammatory breast cancer: which targeted therapies to add on cytotoxic combinations?

Expert Review of Anticancer Therapy
Anthony GonçalvesFrançois Bertucci

Abstract

Inflammatory breast cancer is a rare but frequently fatal disease, essentially because of its high ability to develop distant metastases. Even though the prognosis of IBC was significantly improved by multimodal management, including the systematic use of cytotoxic-based induction, the prognosis remains largely dismal. Areas covered: This review presents the main achievements in the systemic treatment of IBC during the past 30 years. It focuses more specifically on recent results obtained with targeted therapies, including anti-HER2 and anti-angiogenic agents. Novel approaches under investigation are presented. Expert commentary: Current management of IBC is subtype-specific and the largest benefit has been achieved in HER2-positive disease. The identification of breakthrough therapeutic advances is eagerly awaited and will require the development of IBC-specific clinical trials. Future clinical investigations should not only aim to increase the pathological response rate but also to eradicate distant metastases, which ultimately lead to patient death.

References

Jul 1, 1995·Annals of Surgical Oncology·R L BauerS B Edge
Aug 9, 1995·International Journal of Cancer. Journal International Du Cancer·P BonnierL Piana
Aug 30, 2000·Nature·C M PerouD Botstein
May 7, 2002·International Journal of Cancer. Journal International Du Cancer·Kazuo ShirakawaHiro Wakasugi
Feb 25, 2003·Cancer Control : Journal of the Moffitt Cancer Center·Henri RocheUNKNOWN PEGASE Group
May 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·George SomloJames H Doroshow
Dec 9, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ilse Van der AuweraLuc Y Dirix
Sep 28, 2005·Breast Cancer Research and Treatment·Celina G KleerSofia D Merajver
Jan 5, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Suparna Bonthala WedamSandra M Swain
Mar 22, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Judith HurleyDennis J Slamon
Jun 1, 2006·Breast Disease·Malcolm R Kell, Monica Morrow
Mar 14, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N CabiogluM Cristofanilli
Oct 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Beth OvermoyerScot C Remick
Jan 24, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen JohnstonNeil L Spector
Mar 1, 2008·Seminars in Oncology·Emmanuelle Charafe-JauffretFrançois Bertucci
Apr 9, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Joseph A SparanoSaid M Sebti
Dec 17, 2009·The Journal of Experimental Medicine·Loise M FranciscoArlene H Sharpe
Dec 24, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Emmanuelle Charafe-JauffretMax S Wicha
Mar 24, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael UntchGunter von Minckwitz
Jul 7, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S DawoodM Cristofanilli
Sep 9, 2010·International Journal of Cancer. Journal International Du Cancer·Moumita Chatterjee, Kenneth L van Golen
Oct 21, 2010·CA: a Cancer Journal for Clinicians·Fredika M RobertsonMassimo Cristofanilli
Dec 14, 2011·The New England Journal of Medicine·José BaselgaUNKNOWN CLEOPATRA Study Group
Jan 5, 2012·Journal of the National Cancer Institute·Rabiya S Tuma
Jan 20, 2012·The Lancet Oncology·Michael UntchUNKNOWN Arbeitsgemeinschaft Gynäkologische Onkologie-Breast (AGO-B) Study Group
Jan 27, 2012·The New England Journal of Medicine·Gunter von MinckwitzUNKNOWN Arbeitsgemeinschaft Gynäkologische Onkologie–Breast Study Groups
Jan 27, 2012·The New England Journal of Medicine·Harry D BearNorman Wolmark
Apr 12, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Valentina GuarneriPierfranco Conte
Sep 25, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H BonnefoiD Cameron

❮ Previous
Next ❯

Citations

Apr 13, 2021·Journal of Advanced Research·Sudpreeda ChainitikunNaoto T Ueno

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Opinion in Obstetrics & Gynecology
Verena Bossung, Nadia Harbeck
Breast Cancer Research : BCR
Florence LereboursRosette Lidereau
© 2022 Meta ULC. All rights reserved